CM
INDV icon

Caption Management’s Indivior Pharmaceuticals INDV Stock Holding History

Caption Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,309
Closed -$1.03M – 1632
2024
Q3 		$978K Buy
100,309
+51,309
+105% +$601K 0.02% 781
2024
Q2 		$790K Buy
+49,000
New +$884K 0.01% 718

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caption Management's INDV Position: Q4 2024 in Review

Caption Management sold out of Indivior Pharmaceuticals (INDV) in Q4 2024, closing a stake of 100,309 shares — an estimated $1.03M sold.

Caption Management first reported a position in INDV in Q2 2024 and held it in 2 quarters. The position peaked at $978K in Q3 2024. 113 funds tracked by Wall St. Rank hold INDV as of Q4 2024.

  • Caption Management reported no remaining Indivior Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Caption Management sold 100,309 Indivior Pharmaceuticals shares in Q4 2024, an estimated $1.03M.
  • Caption Management first reported a position in Indivior Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • Caption Management's Indivior Pharmaceuticals position peaked at $978K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.